This September, as we all await the successful launch of Artemis 1, we at TrialX are gearing up to demo how we are enabling decentralized clinical research in commercial space missions at the Mobile Tech in Clinical Trials 2022 conference on September 12, 2022. Our CEO Dr. Sharib Khan will share how technologies used in space health research are providing a blueprint for decentralized clinical trials on earth and demonstrate how the TrialX xPAND platform used by the Translational Research Institute for Space Health (TRISH) is pushing the envelope of research.
The launch of the first all-civilian mission to space in Sep 2021 marked a new era of commercial space travel which has created the opportunity to study the effect of space and microgravity on civilians as opposed to highly selective space agency astronauts. Each such mission requires collecting a variety of data types and in several cases, by the research subjects – aka private astronauts – themselves, to collect a variety of biomedical data (biosamples, ultrasounds, surveys, cognitive assessments). Furthermore, to accelerate the understanding of space travel on human health, it is imperative that data be shared across researchers, missions and flight operators, thus going beyond the usual siloed study by study data models.
To equip space researchers to reuse and integrate research data across different research studies and unlock innovative actionable insights we built the xPAND database. Used by researchers at TRISH, xPAND database now has the data of 9 commercial space astronauts across 3 space missions.
“This is the first such database of human health and environmental data from commercial space flights. The database has been architected to support a variety of data types across multitude of individual research studies so as to support open research with appropriate privacy and data control safeguards. We believe that such models that empower participants to actively source data, support cross study data linkages and collaboration, may also accelerate drug development, here on earth” says Dr. Chintan Patel, the CTO and co-founder of TrialX.
Supporting clinical research in space missions provides an opportunity to build systems with multi-stakeholder collaboration and long term data reuse as key considerations. Such models could potentially accelerate drug development here on earth by fostering data re-use across studies.
We look forward to seeing you at the live tech demo session at 12:10 PM on September 12, 2022. If you would like to learn more about xPAND or schedule a meeting with Dr. Khan during the conference, get in touch.
Here’s our scheduling link if you would like to avoid the back and forth of finding a time to meet Dr. Khan calendly.com/trialx
